[HTML][HTML] Artificial intelligence for diabetes management and decision support: literature review
Background Artificial intelligence methods in combination with the latest technologies,
including medical devices, mobile computing, and sensor technologies, have the potential to …
including medical devices, mobile computing, and sensor technologies, have the potential to …
Artificial intelligence and machine learning for improving glycemic control in diabetes: Best practices, pitfalls, and opportunities
Objective: Artificial intelligence and machine learning are transforming many fields including
medicine. In diabetes, robust biosensing technologies and automated insulin delivery …
medicine. In diabetes, robust biosensing technologies and automated insulin delivery …
Closed-loop insulin delivery systems: past, present, and future directions
S Templer - Frontiers in Endocrinology, 2022 - frontiersin.org
Closed-loop (artificial pancreas) systems for automated insulin delivery have been likened
to the holy grail of diabetes management. The first iterations of glucose-responsive insulin …
to the holy grail of diabetes management. The first iterations of glucose-responsive insulin …
Wearable glucose monitoring and implantable drug delivery systems for diabetes management
The global cost of diabetes care exceeds 1trillioneachyearwithmorethan 327 billion being
spent in the United States alone. Despite some of the advances in diabetes care including …
spent in the United States alone. Despite some of the advances in diabetes care including …
Artificial intelligence in decision support systems for type 1 diabetes
Type 1 diabetes (T1D) is a chronic health condition resulting from pancreatic beta cell
dysfunction and insulin depletion. While automated insulin delivery systems are now …
dysfunction and insulin depletion. While automated insulin delivery systems are now …
Realizing a closed-loop (artificial pancreas) system for the treatment of type 1 diabetes
RA Lal, L Ekhlaspour, K Hood… - Endocrine …, 2019 - academic.oup.com
Recent, rapid changes in the treatment of type 1 diabetes have allowed for
commercialization of an “artificial pancreas” that is better described as a closed-loop …
commercialization of an “artificial pancreas” that is better described as a closed-loop …
MiniMed 670G hybrid closed loop artificial pancreas system for the treatment of type 1 diabetes mellitus: overview of its safety and efficacy
A Saunders, LH Messer… - Expert review of medical …, 2019 - Taylor & Francis
Introduction: Automated insulin delivery for people with type 1 diabetes has been a major
goal in the diabetes technology field for many years. While a fully automated system has not …
goal in the diabetes technology field for many years. While a fully automated system has not …
A clinical guide to advanced diabetes devices and closed-loop systems using the CARES paradigm
Advanced diabetes devices are the most sophisticated technologies available for self-
management of insulinrequiring diabetes. 1, 2 Advanced diabetes devices are insulin …
management of insulinrequiring diabetes. 1, 2 Advanced diabetes devices are insulin …
Advanced closed-loop control system improves postprandial glycemic control compared with a hybrid closed-loop system following unannounced meal
OBJECTIVE Meals are a major hurdle to glycemic control in type 1 diabetes (T1D). Our
objective was to test a fully automated closed-loop control (CLC) system in the absence of …
objective was to test a fully automated closed-loop control (CLC) system in the absence of …
A deep learning framework for automatic meal detection and estimation in artificial pancreas systems
Current artificial pancreas (AP) systems are hybrid closed-loop systems that require manual
meal announcements to manage postprandial glucose control effectively. This poses a …
meal announcements to manage postprandial glucose control effectively. This poses a …